Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia
PLOS Medicine: Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
Cancer risk and PTEN gene mutations
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine in: Endocrine-Related Cancer Volume 25 Issue 8 (2018)
Cleveland Clinic Designated PTEN Clinical Center of Excellence – Consult QD
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity | NEJM
References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
Rare Diseases Clinical Research Network (RDCRN) - PTEN hamartoma tumor syndrome is a genetic condition in which non-cancerous growths, called hamartomas, develop in different areas of the body. The disease is hereditary,
How are new medicines developed? | PTEN Research
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology
Cleveland Clinic's 4th Annual International PTEN Symposium
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
Pharmacological PTEN inhibition: potential clinical applications and effects in tissue regeneration | Regenerative Medicine
PTEN hamartoma tumor syndromes | European Journal of Human Genetics
AstraZeneca and Babraham Unravel the Mystery of a Major Cancer Gene
Finally in the game: Patient in drug trial for PTEN mutation seems to benefit - Boston Children's Answers Early patient in drug trial for PTEN mutation seems to benefit
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) - European Journal of Cancer
JCI - PTEN-opathies: from biological insights to evidence-based precision medicine
